(1.01%) 5 086.49 points
(1.31%) 38 310 points
(1.39%) 15 875 points
(-3.31%) $79.22
(-2.46%) $1.942
(1.39%) $2 335.00
(1.90%) $27.16
(1.87%) $965.90
(-0.53%) $0.932
(-0.73%) $11.01
(-0.36%) $0.797
(-0.48%) $93.00
Live Chart Being Loaded With Signals
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China...
Stats | |
---|---|
本日の出来高 | 4.88M |
平均出来高 | 4.05M |
時価総額 | 8.93B |
EPS | HKD0 ( 2023-10-26 ) |
Last Dividend | HKD0.340 ( 2023-06-09 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 4.33 |
ATR14 | HKD0.00200 (0.04%) |
ボリューム 相関
Genertec Universal 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Genertec Universal 相関 - 通貨/商品
Genertec Universal 財務諸表
Annual | 2023 |
収益: | HKD13.65B |
総利益: | HKD4.57B (33.49 %) |
EPS: | HKD1.070 |
FY | 2023 |
収益: | HKD13.65B |
総利益: | HKD4.57B (33.49 %) |
EPS: | HKD1.070 |
FY | 2022 |
収益: | HKD11.57B |
総利益: | HKD4.14B (35.79 %) |
EPS: | HKD1.000 |
FY | 2021 |
収益: | HKD9.91B |
総利益: | HKD4.20B (42.36 %) |
EPS: | HKD0.990 |
Financial Reports:
No articles found.
Genertec Universal Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.340 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.130 | 2016-06-10 |
Last Dividend | HKD0.340 | 2023-06-09 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | HKD2.11 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.87 | -- |
Div. Sustainability Score | 9.45 | |
Div.Growth Potential Score | 5.79 | |
Div. Directional Score | 7.62 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2283.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
1270.HK | Ex Dividend Knight | 2023-05-16 | Annually | 0 | 0.00% | |
0323.HK | No Dividend Player | 2023-06-21 | Sporadic | 0 | 0.00% | |
6055.HK | Ex Dividend Knight | 2023-06-13 | Annually | 0 | 0.00% | |
1821.HK | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
0856.HK | Ex Dividend Junior | 2023-05-31 | Annually | 0 | 0.00% | |
0010.HK | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
2601.HK | Ex Dividend Knight | 2023-05-30 | Annually | 0 | 0.00% | |
1397.HK | Ex Dividend Junior | 2023-06-21 | Sporadic | 0 | 0.00% | |
0460.HK | Ex Dividend Junior | 2023-06-06 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.150 | 1.500 | 7.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0252 | 1.200 | 9.16 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.118 | 1.500 | 9.80 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.293 | -1.000 | 7.07 | -7.07 | [0 - 1] |
currentRatioTTM | 1.021 | 0.800 | 9.90 | 7.92 | [1 - 3] |
quickRatioTTM | 0.120 | 0.800 | -4.00 | -3.20 | [0.8 - 2.5] |
cashRatioTTM | 0.118 | 1.500 | -0.457 | -0.686 | [0.2 - 2] |
debtRatioTTM | 0.649 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.45 | 2.00 | 9.18 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.01 | 2.00 | 8.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 3.01 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.206 | 1.000 | 7.88 | 7.88 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0957 | 1.000 | -0.579 | -0.579 | [0.2 - 2] |
assetTurnoverTTM | 0.168 | 0.800 | -2.22 | -1.773 | [0.5 - 2] |
Total Score | 9.45 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.31 | 1.000 | 9.67 | 0 | [1 - 100] |
returnOnEquityTTM | 0.118 | 2.50 | 9.87 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.01 | 2.00 | 9.33 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 7.95 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.45 | 2.00 | 9.18 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.293 | 1.500 | 7.07 | -7.07 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.371 | 1.000 | 3.23 | 0 | [0.1 - 0.5] |
Total Score | 5.79 |
Genertec Universal
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group segment engages in the provision of medical services; hospital and healthcare management; and import and export trading businesses, as well as trading of medical-related goods. The company is also involved in the provision of medical technology; hospital digitalization, construction, and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。